Artiva Biotherapeutics, Inc. · NASDAQ:ARTV
Ra Capital Management, L.P. reported a 33.70% stake in Artiva Biotherapeutics, Inc. (Schedule 13D/A)
Event May 11, 2026 · Filed May 13, 2026
Ra Capital Management, L.P. reported a 33.70% stake in Artiva Biotherapeutics, Inc., 16,377,468 shares, with active intent on May 11, 2026. Filed May 13, 2026 (Schedule 13D/A).
- Stake
- 33.70%
- Shares
- 16,377,468
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 33.70% | 16,377,468 |
| Peter Kolchinsky | 33.70% | 16,377,468 |
| Rajeev Shah | 33.70% | 16,377,468 |
| RA Capital Healthcare Fund, L.P. | 31.30% | 15,203,995 |
Source
Related
- Artiva Biotherapeutics, Inc.
- Ra Capital Management, L.P.
- Artiva Biotherapeutics, Inc. shareholders
- Schedule 13D/A · Ra Capital Management, L.P. · Jul 23, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jun 15, 2026
- Form 4 · Aslan Fred · Oct 7, 2026
- Form 4 · Aslan Fred · Oct 6, 2026
- Form 4 · Banerjee Subhashis · Oct 6, 2026
- Form 4 · Bush Jennifer · Oct 6, 2026
- Form 4 · Horan Christopher · Oct 6, 2026